Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Dec 9, 2010
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how our genes may influence the risks of certain complications after heart surgery, such as irregular heartbeats (atrial fibrillation), heart attacks (myocardial infarction), kidney problems, and heart failure. Researchers are trying to find out if there are specific genetic traits that make some patients more likely to experience these issues after undergoing surgery.
If you or a loved one are planning to have heart surgery at Brigham and Women's Hospital or the Texas Heart Institute, you may be eligible to participate in this study, as long as you are willing to give your consent and are not currently involved in another drug or device trial. Participants can expect to provide genetic information, which could help doctors understand and potentially reduce the risks of these complications in the future. This study is actively recruiting patients of all ages, so if you're interested, it could be a great opportunity to contribute to important heart health research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing heart surgery
- • Willing to provide consent
- Exclusion Criteria:
- • Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Dallas, Texas, United States
Houston, Texas, United States
Patients applied
Trial Officials
Jochen D Muehlschlegel, MD MMSc, MPH
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials